Results 91 to 100 of about 295,380 (280)

Duodenal-Type Follicular Lymphoma

open access: yes, 2023
This case report presents the clinical findings, diagnostic evaluation, and treatment options for a 71-year-old female patient with a medical history of hypertension, dyslipidemia, and recurrent urinary tract infections.
Afra Abdulla Juma   +3 more
core   +1 more source

Visual Parathyroid Identification in Thyroidectomy: A Decision Curve Analysis of Gland Preservation

open access: yesThe Laryngoscope, EarlyView.
Intraoperative visual identification remains the standard approach to parathyroid preservation during thyroidectomy, yet its accuracy has rarely been quantified against an objective reference. Among 50 suspected parathyroid specimens verified by fine‐needle aspiration PTH washout, expert consensus visual identification achieved 84.0% sensitivity but ...
Paveena Pithuksurachai   +5 more
wiley   +1 more source

Follicular Lymphoma [PDF]

open access: yesEar, Nose & Throat Journal, 2006
Liron, Pantanowitz, Lester D R, Thompson
openaire   +2 more sources

Axicabtagene Ciloleucel in the Management of Follicular Lymphoma: Current Perspectives on Clinical Utility, Patient Selection and Reported Outcomes

open access: yes, 2023
Razan Mohty,1 Mohamed A Kharfan-Dabaja,2 Julio C Chavez3 1Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, FL, USA; 2Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular ...
Kharfan-Dabaja MA, Mohty R, Chavez JC
core  

Simultaneous Presentation of Follicular Lymphoma and Diffuse Large B-cell lymphoma (DLBCL): A Case Report

open access: yesIndonesian Journal of Cancer
Introduction: The natural history of follicular lymphoma (FL) is frequently characterized by transformation to a more aggressive diffuse large B-cell lymphoma (DLBCL).
Rosmeri Handayani, Agus Susanto Kosasih
doaj   +1 more source

Treatment of Follicular Lymphoma

open access: yesJournal of Clinical and Experimental Hematopathology, 2014
Follicular lymphoma (FL) is the most common subtype of indolent lymphomas. Several lines of evidence suggest that the prognosis of patients with FL has improved since the introduction of rituximab, although cure cannot be achieved. Although the treatment paradigm for FL has changed over the past decade with the introduction of rituximab and other ...
openaire   +3 more sources

MR‐Linac Successfully Guided the Treatment of a Free‐Moving Mesenteric Mass

open access: yesPrecision Radiation Oncology, EarlyView.
This case demonstrated that a mesenteric tumor could move significantly day‐to‐day in all directions with large volume change. MR‐Linac with online adaptive capability provided a superior platform to treat mobile target with significantly reduced normal tissue exposure to radiation .
Xin Wang   +4 more
wiley   +1 more source

Diagnostic Challenges in Nodal T-Follicular Helper (TFH) Cell Lymphoma

open access: yesBioMed
Nodal T-follicular helper cell lymphomas comprise a biologically similar but morphologically diverse family of T-cell neoplasms, including angioimmunoblastic T-cell lymphoma, nodal T-follicular helper cell lymphoma, follicular-type, and nodal TFH ...
Neha Seth   +2 more
doaj   +1 more source

Artificial intelligence empowers targeted protein degradation: Core technological innovations, multi‐scenario applications, and translational prospects

open access: yesSmart Molecules, EarlyView.
AI is transforming TPD by improving the design, prediction, and optimization of degraders such as PROTACs, molecular glues, and LYTACs. This review summarizes key AI‐driven advances, highlights applications across drug discovery stages, and discusses remaining challenges and future directions for accelerating the development of therapies against ...
Shuanglin Qin   +10 more
wiley   +1 more source

Pathology of Follicular Lymphoma

open access: yesJournal of Clinical and Experimental Hematopathology, 2014
Follicular lymphoma (FL) is a heterogeneous disease, and there are many different subgroups, such as in terms of age of onset, involved organ (especially extranodal sites such as gastrointestinal tract) and genetic abnormality. Grade 3B is currently regarded as a distinct entity by molecular genetic analyses, but the independence of Grade 3A remains ...
Takata, Katsuyoshi   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy